SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-024215
Filing Date
2022-11-10
Accepted
2022-11-10 09:10:36
Documents
16
Period of Report
2022-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tngx-20220810.htm   iXBRL 8-K 56198
2 EX-99.1 tngx-ex99_1.htm EX-99.1 321565
3 GRAPHIC img21139354_0.jpg GRAPHIC 26351
4 GRAPHIC img159114951_0.jpg GRAPHIC 778
  Complete submission text file 0000950170-22-024215.txt   582884

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tngx-20220810_lab.xml EX-101.LAB 17583
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tngx-20220810_def.xml EX-101.DEF 14249
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tngx-20220810_pre.xml EX-101.PRE 13930
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tngx-20220810.xsd EX-101.SCH 2896
10 EXTRACTED XBRL INSTANCE DOCUMENT tngx-20220810_htm.xml XML 4873
Mailing Address 100 BINNEY ST SUITE 700 CAMBRIDGE MA 02142
Business Address 100 BINNEY ST SUITE 700 CAMBRIDGE MA 02142 (857) 320-4900
Tango Therapeutics, Inc. (Filer) CIK: 0001819133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39485 | Film No.: 221375253
SIC: 2834 Pharmaceutical Preparations